Jay Matushak - Oct 4, 2024 Form 4 Insider Report for NeueHealth, Inc. (NEUE)

Role
Chief Financial Officer
Signature
/s/ Eric Halverson for Jay Matushak, Attorney-in-Fact
Stock symbol
NEUE
Transactions as of
Oct 4, 2024
Transactions value $
-$451
Form type
4
Date filed
10/8/2024, 06:08 PM
Previous filing
May 13, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NEUE Common Stock Options Exercise +263 +2.83% 9.57K Oct 4, 2024 Direct F1
transaction NEUE Common Stock Sale -$451 -87 -0.91% $5.18 9.48K Oct 7, 2024 Direct F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NEUE Restricted Stock Units Options Exercise $0 -263 -100% $0.00 0 Oct 4, 2024 Common Stock 263 Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
F2 These shares were sold by the reporting person to cover tax withholding obligations upon the vesting of restricted stock units and were not discretionary transactions by the reporting person.
F3 These shares were sold in multiple transactions, all at $5.18 per share. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold in each such transaction.
F4 These restricted stock units vested over three years as follows: (a) one-third of the original grant amount vested on October 4, 2022, (b) one-third of the original grant amount vested on October 4, 2023, (c) and one-third of the original grant amount vested on October 4, 2024.